These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15564966)

  • 1. Treatment of rebound pulmonary hypertension: why not sildenafil?
    Raja SG
    Anesthesiology; 2004 Dec; 101(6):1480; author reply 1481. PubMed ID: 15564966
    [No Abstract]   [Full Text] [Related]  

  • 2. Sildenafil treatment of primary pulmonary hypertension.
    Laupland KB; Helmersen D; Zygun DA; Viner SM
    Can Respir J; 2003; 10(1):48-50. PubMed ID: 12624621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
    Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.
    Porta NF; Steinhorn RH
    Clin Perinatol; 2012 Mar; 39(1):149-64. PubMed ID: 22341543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
    Humbert M
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
    [No Abstract]   [Full Text] [Related]  

  • 6. Transient effect of epoprostenol and sildenafil combined with iNO for pulmonary hypertension in congenital diaphragmatic hernia.
    De Luca D; Zecca E; Vento G; De Carolis MP; Romagnoli C
    Paediatr Anaesth; 2006 May; 16(5):597-8. PubMed ID: 16677275
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination of sildenafil and bosentan for nitric oxide withdrawal.
    Behrends M; Beiderlinden M; Peters J
    Eur J Anaesthesiol; 2005 Feb; 22(2):155-7. PubMed ID: 15816597
    [No Abstract]   [Full Text] [Related]  

  • 8. Summaries for patients. A combination treatment for pulmonary hypertension.
    Ann Intern Med; 2008 Oct; 149(8):I-38. PubMed ID: 18936497
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension.
    Klinger JR; Thaker S; Houtchens J; Preston IR; Hill NS; Farber HW
    Chest; 2006 Feb; 129(2):417-425. PubMed ID: 16478861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil for pulmonary hypertension in pregnancy?
    Lynch TD; Laffey JG
    Anesthesiology; 2006 Feb; 104(2):382; author reply 383. PubMed ID: 16436871
    [No Abstract]   [Full Text] [Related]  

  • 12. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children.
    Namachivayam P; Theilen U; Butt WW; Cooper SM; Penny DJ; Shekerdemian LS
    Am J Respir Crit Care Med; 2006 Nov; 174(9):1042-7. PubMed ID: 16917115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase inhibitors in the management of primary pulmonary hypertension.
    Jue VI
    Prog Cardiovasc Nurs; 2004; 19(2):74-9. PubMed ID: 15133384
    [No Abstract]   [Full Text] [Related]  

  • 14. Sildenafil can increase the response to inhaled nitric oxide.
    Bigatello LM; Hess D; Dennehy KC; Medoff BD; Hurford WE
    Anesthesiology; 2000 Jun; 92(6):1827-9. PubMed ID: 10839936
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
    Lee JE; Hillier SC; Knoderer CA
    J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension.
    Stiebellehner L; Petkov V; Vonbank K; Funk G; Schenk P; Ziesche R; Block LH
    Chest; 2003 Apr; 123(4):1293-5. PubMed ID: 12684325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent Pulmonary Hypertension of the Newborn: Should Sildenafil and Inhaled Nitric Oxide at Medium Concentration Be the Standard of Treatment?
    Florez ID; Parra-Rodas L
    Crit Care Med; 2024 Jun; 52(6):995-997. PubMed ID: 38752821
    [No Abstract]   [Full Text] [Related]  

  • 18. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
    Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
    Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH).
    Suntharalingam J; Hughes RJ; Goldsmith K; Doughty N; George P; Toshner M; Sheares KK; Pepke-Zaba J
    Vascul Pharmacol; 2007 Jun; 46(6):449-55. PubMed ID: 17368113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil for "blue babies". Such unlicensed drug use might be justified as last resort.
    Oliver J; Webb DJ
    BMJ; 2002 Nov; 325(7373):1174. PubMed ID: 12433774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.